Yidu Technology (02158) rose more than 9% and rose 9.27% at press time to HK$4.48, with a turnover of HK$26.51 million.
The Zhitong Finance App learned that Yidu Technology (02158) rose by more than 9% and rose 9.27% at press time to HK$4.48, with a turnover of HK$26.51 million.
According to news, at the Nvidia GTC conference, which will open on the 18th, there were 90 healthcare/life sciences-related events — the highest number of all industries, surpassing popular fields such as automobiles, cloud services, and hardware/semiconductors. “Some say we are Nvidia's next multi-billion dollar business,” Kimberly Powell, vice president of healthcare at Nvidia, said in an interview a few days ago. She said Nvidia's goal is to provide more biotech companies with chips, cloud infrastructure, and other tools.
According to reports, Yidu Technology's self-developed large model is a large professional language model for multiple scenarios in the medical vertical field, and is also a large model that is fully adapted to Shengteng AI in the medical field; currently, the evaluation performance in various clear medical task scenarios such as segmentation, basic medicine, general medicine, clinical internal medicine, clinical surgery, and practice qualification examinations has exceeded GPT 3.5, and the accuracy rate and recall rate for data structuring tasks are far higher than the large model with the same parameters. The company positioned the big model as a next-generation “medical superbrain”, and applications have now been implemented on the C-side and B-side.